Home » Topics » Regulatory » EMA

EMA
RSS

EMA accepts Epidiolex MAA for review

Feb. 6, 2018

EMA accepts fremanezumab MAA

Feb. 5, 2018

Pfizer reflects on milestones of fourth quarter 2017

Feb. 5, 2018

EMA committee recommends approval of biosimilar insulin glargine Semglee

Jan. 31, 2018

EMA committee recommends approval of use of Ameluz with daylight PDT

Jan. 31, 2018

Rexgenero receives ATMP certificate from EMA for REX-001

Jan. 31, 2018

EMA committee recommends approval of Lamzede for alpha-mannosidosis

Jan. 30, 2018

EMA committee hands down negative opinion for enclomiphene MAA

Jan. 29, 2018

EMA committee recommends approval of Hemlibra in hemophilia A

Jan. 29, 2018

CHMP supports approval of Shingrix for prevention of shingles in adults aged 50 and over

Jan. 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...